van Lankveld Marieke A L, Koot Nicole C M, Peeters Petra H M, van Leeuwen Jules Schagen, Jürgenliemk-Schulz Ina M, van Eijkeren Marion A
University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
J Eval Clin Pract. 2006 Apr;12(2):196-201. doi: 10.1111/j.1365-2753.2006.00618.x.
RATIONALE, AIMS AND OBJECTIVES: We evaluated the adherence to treatment guidelines in early stage endometrial cancer and the influence of adherence to guidelines on overall survival.
Patients were identified in the central region in the Netherlands from 1990 till 1995. Patient and tumour characteristics, surgical findings, radiation and follow-up data were abstracted from medical records. Endpoint was overall survival. Kaplan-Meier method was used to perform time-to-event analysis. Hazard ratios for overall survival were estimated with a Cox Proportional Hazards model.
359 patients were eligible for analysis. 335 patients presented with a clinical stage I cancer. 333 patients underwent a Total Abdominal Hysterectomy with Bilateral Salpingo Oophorectomy (TAH/BSO), of which 301 were staged as International Federation of Gynaecology and Obstetrics (FIGO) stage I, whereas 34 (10.2%) as FIGO stage II. Of the 24 patients with a clinical stage II cancer, 12 underwent a Radical Hysterectomy with Pelvic Lymph Node Dissection (RH/PLND), of which seven were diagnosed with FIGO stage II. In 72.1% of the patients adjuvant radiation was given or not in adherence to the guidelines. Whether treatment was given according to the guidelines or not did not affect 5 years overall survival.
This suggests that extensive surgical procedures are redundant in the treatment of occult stage II endometrial cancer.
原理、目的和目标:我们评估了早期子宫内膜癌患者对治疗指南的依从性以及依从指南对总生存期的影响。
研究对象为1990年至1995年荷兰中部地区的患者。从医疗记录中提取患者和肿瘤特征、手术结果、放疗及随访数据。终点指标为总生存期。采用Kaplan-Meier方法进行事件发生时间分析。使用Cox比例风险模型估计总生存期的风险比。
359例患者符合分析条件。335例患者为临床I期癌症。333例患者接受了全腹子宫切除加双侧输卵管卵巢切除术(TAH/BSO),其中301例分期为国际妇产科联盟(FIGO)I期,34例(10.2%)为FIGO II期。24例临床II期癌症患者中,12例接受了根治性子宫切除加盆腔淋巴结清扫术(RH/PLND),其中7例被诊断为FIGO II期。72.1%的患者辅助放疗的给予与否符合指南。治疗是否遵循指南并不影响5年总生存期。
这表明在隐匿性II期子宫内膜癌的治疗中,广泛的手术操作是多余的。